BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 4349046)

  • 21. The use of cryopreserved human thyroid tissue for the in vitro assay of thyroid stimulators.
    Knox AJ; von Westarp C; Row VV; Volpé R
    Cryobiology; 1977 Oct; 14(5):543-8. PubMed ID: 198180
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients.
    Maayan ML; Volpert EM; Dawry FP
    J Endocrinol Invest; 1978 Oct; 1(4):299-304. PubMed ID: 92490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE; Burke G
    Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
    [No Abstract]   [Full Text] [Related]  

  • 25. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
    Tourneur R; Letonturier P; Sénécal P
    MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
    [No Abstract]   [Full Text] [Related]  

  • 26. Isoelectric focusing of thyroid-stimulating antibody of Graves' disease.
    Zakarija M; McKenzie JM
    Endocrinology; 1978 Oct; 103(4):1469-75. PubMed ID: 33803
    [No Abstract]   [Full Text] [Related]  

  • 27. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
    Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenylate cyclase activity and the accumulation and release of adenosine 3',5'-monophosphate in normal human thyroid tissue slice preparations: responses to thyrotropin and thyroid-stimulating antibodies.
    Bidey SP; Marshall NJ; Ekins RP
    J Clin Endocrinol Metab; 1981 Aug; 53(2):246-53. PubMed ID: 6114107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L.A.T.S. and Graves' disease.
    Hedley AJ; Ross IP; Crooks J
    Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on thyroid stimulating hormone and the long-acting thyroid stimulating hormone.
    Bitensky L; Alaghband-Zadeh J; Chayen J
    Clin Endocrinol (Oxf); 1974 Jul; 3(3):363-74. PubMed ID: 4837956
    [No Abstract]   [Full Text] [Related]  

  • 31. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
    McKenzie JM; McCullagh EP
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of cyclic 3',5'-adenosine monophosphate and dibutyryl cyclic 3',5'-adenosine monophosphate on basal and stimulated thyroid function.
    Burke G
    J Clin Endocrinol Metab; 1968 Dec; 28(12):1816-23. PubMed ID: 4301766
    [No Abstract]   [Full Text] [Related]  

  • 33. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1095-102. PubMed ID: 4166580
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 35. The immunoglobulin G (IgG) of Graves' disease: thyroid stimulation by fraction and fragment.
    Burke G
    Endocrinology; 1969 May; 84(5):1063-70. PubMed ID: 4887860
    [No Abstract]   [Full Text] [Related]  

  • 36. Influences of cholera toxin on thyroid stimulation by thyrotropin and thyroid-stimulating antibody.
    Zakarija M; McKenzie JM
    Endocrinology; 1980 Dec; 107(6):2051-4. PubMed ID: 6107244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assays of thyroid-stimulating antibody.
    McKenzie JM; Zakarija M
    Methods Enzymol; 1985; 109():677-91. PubMed ID: 2859517
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of early effects of thyrotropin and long-acting thyroid stimulator on thyroid secretion.
    Shishiba Y; Solomon DH; Beall GN
    Endocrinology; 1967 May; 80(5):957-61. PubMed ID: 6023563
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

  • 40. The long-acting thyroid stimulator.
    Munro DS
    Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.